Informatics of drug synergism in naturally occurring anticancer agents.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Recent Patents on Anti-Cancer Drug Discovery

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.2174/157489211793980105PMID 21110822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells.

  2010cited by this paper
• (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.

  2010cited by this paper
• Multidrug Resistance Reversal Agent, NSC77037, Identified with a Cell-Based Screening Assay

  2010cited by this paper
• Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.

  2010cited by this paper
• Overcoming multidrug-resistance in cancer: statins offer a logical candidate.

  2010cited by this paper
• Natural compounds for cancer treatment and prevention.

  2009cited by this paper
• Anticancer drug discovery in the future: an evolutionary perspective.

  2009cited by this paper
• Novel dihydro-beta-agarofuran sesquiterpenes as potent modulators of human P-glycoprotein dependent multidrug resistance.

  2009cited by this paper
• Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

  2009cited by this paper
• Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach.

  2009cited by this paper
• Ready for a comeback of natural products in oncology.

  2009cited by this paper
• Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.

  2009cited by this paper
• Cheminformatics based selection and cytotoxic effects of herbal extracts.

  2009cited by this paper
• Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.

  2008cited by this paper
• Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.

  2008cited by this paper
• Pharmacophore mapping of arylbenzothiophene derivatives for MCF cell inhibition using classical and 3D space modeling approaches.

  2008cited by this paper
• Evidence of a novel docetaxel sensitizer, garlic‐derived S‐allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer

  2008cited by this paper
• Simulation of Different Truncated p16INK4a Forms and In Silico Study of Interaction with Cdk4

  2008cited by this paper
• Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.

  2007cited by this paper
• 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.

  2007cited by this paper
• Wogonin, a Plant Flavone, Potentiates Etoposide‐Induced Apoptosis in Cancer Cells

  2007cited by this paper
• Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.

  2007cited by this paper
• Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids.

  2007cited by this paper
• Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells.

  2007cited by this paper
• Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells

  2007cited by this paper
• Role of Triptolide as an Adjunct Chemotherapy for Ovarian Cancer

  2007cited by this paper
• Contribution of oncoproteomics to cancer biomarker discovery

  2007cited by this paper
• Recent advances in chemoinformatics.

  2007cited by this paper
• Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study.

  2007cited by this paper
• First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.

  2007cited by this paper
• Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.

  2007cited by this paper
• Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism

  2007cited by this paper
• Computational approaches to modeling drug transporters.

  2006cited by this paper
• 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.

  2006cited by this paper
• Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line

  2006cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.

  2006cited by this paper
• Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro.

  2006cited by this paper
• Deciphering cellular states of innate tumor drug responses

  2006cited by this paper
• Antitumor Efficacy of the Novel Chemotherapeutic Agent Coramsine Is Potentiated by Cotreatment With CpG-Containing Oligodeoxynucleotides

  2006cited by this paper
• The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research

  2006cited by this paper
• Pretreatment with neem (Azadirachta indica) leaf preparation in swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide

  2006cited by this paper
• Application of data mining approaches to drug delivery.

  2006cited by this paper
• Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.

  2006cited by this paper
• Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.

  2006cited by this paper
• Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

  2006cited by this paper
• Knowledge-based chemoinformatic approaches to drug discovery.

  2006cited by this paper
• Antiproliferative Activities of Parthenolide and Golden Feverfew Extract Against Three Human Cancer Cell Lines

  2006cited by this paper
• Chemoinformatics: a new field with a long tradition

  2006cited by this paper
• Correcting ligands, metabolites, and pathways

  2006cited by this paper
• Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.

  2005cited by this paper
• Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells.

  2005cited by this paper
• Nonpeptidic Small-Molecule Inhibitor of Bcl-2 and Bcl-XL, (−)-Gossypol, Enhances Biological Effect of Genistein Against BxPC-3 Human Pancreatic Cancer Cell Line

  2005cited by this paper
• Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo.

  2005cited by this paper
• Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Drug discovery from medicinal plants.

  2005cited by this paper
• Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates

  2005cited by this paper
• Gene expression microarray technologies in the development of new therapeutic agents.

  2004cited by this paper
• Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate.

  2004cited by this paper
• Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells.

  2003cited by this paper
• Molecular cancer therapeutics: recent progress and targets in drug resistance.

  2003cited by this paper
• Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment.

  2002cited by this paper
• Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

  2001cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

  2000cited by this paper
• Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules.

  2000cited by this paper
• Neutral taxoids from Taxus cuspidata as modulators of multidrug-resistant tumor cells.

  2000cited by this paper
• An informatics approach identifying markers of chemosensitivity in human cancer cell lines.

  2000cited by this paper
• Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats.

  1998cited by this paper
• Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues

  1998cited by this paper
• Torilin, a sesquiterpene from Torilis japonica, reverses multidrug-resistance in cancer cells.

  1998cited by this paper
• Quantitative structure-activity relationship of multidrug resistance reversal agents.

  1997cited by this paper
• Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.

  1996cited by this paper

• “Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”

  2025cites this paper
• The therapeutic value of alstonine: An updated review

  2023cites this paper
• Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux

  2019cites this paper
• Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.

  2019cites this paper
• Natural scaffolds in anticancer therapy and precision medicine.

  2018cites this paper
• Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines.

  2017cites this paper
• Lung cancer inhibitory activity of dietary berries and berry polyphenolics

  2016cites this paper
• Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis

  2014cites this paper
• Taurine enhances anticancer activity of cisplatin in human cervical cancer cells.

  2013cites this paper
• Gene Expression Profile of the A549 Human Non-Small Cell Lung Carcinoma Cell Line following Treatment with the Seeds of Descurainia sophia, a Potential Anticancer Drug

  2013cites this paper
• The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development

  2013cites this paper
• Efficacy and Safety of Artemether in the Treatment of Chronic Fascioliasis in Egypt: Exploratory Phase-2 Trials

  2011cites this paper